The Lymphoma Research Foundation (LRF) is proud to announce it has awarded 16 grants totaling $1.375 million to early career and disease-specific scientists based at many of the world’s leading cancer research institutes. The 2020 LRF research portfolio includes grants…
Download the Understanding COVID-19/Novel Coronavirus: What Patients Need to Know Fact Sheet. What is COVID-19/coronavirus disease? The novel SARS-CoV-2 coronavirus that has recently been in the news is a virus that has not been previously identified. The virus currently causing…
Lymphoma Research Foundation Statement on COVID-19 and LRF Programs and Events Update: Effective May 12, 2021, the Lymphoma Research Foundation will resume outdoor events. Indoor programs and events will remain virtual. Visit the COVID-19 Learning Center for more information regarding…
Due to an increase in new and effective treatments, outcomes among lymphoma patients have improved, with a 10-year survival rate reported to be higher than 50 percent for many subtypes. With more patients living with and after a lymphoma diagnosis,…
In our increasingly interconnected world, people are using social media to support nonprofits—how can you make the biggest impact? When the first-ever telethon was hosted in 1949, the idea of pledging charitable donations over the phone was new but caught…
Understanding Cancer-Related Financial Toxicity Cancer is one of the costliest conditions to treat today in the United States. With outcomes among patients with lymphoma improving, managing costs related to the diagnosis and treatment of their disease is a major concern.…
The Lymphoma Research Foundation is proud to launch its new flagship publication, Pulse. Published quarterly, Pulse provides the latest updates on the Foundation and its focus on lymphoma and chronic lymphocytic leukemia (CLL) research, awareness and education. Pulse will also…